A medical diagnostics technology company

About Rhythm Biosciences

Rhythm Biosciences – simple, accurate, and patient friendly blood tests for the detection of cancer

Rhythm Biosciences is an innovative Australian, publicly listed medical diagnostics company, with a focus on delivering simple, affordable blood tests for the accurate detection of cancers, providing physicians with accurate and reliable diagnostic tools.

Early detection is critical to improving patient outcomes and reducing the global burden of cancer.

ColoSTAT®, Rhythm Bioscience’s first simple blood-based cancer test, designed for the early detection of colorectal cancer, is an alternative screening test for individuals unable to or are unwilling to use currently available screening modalities. The test is being updated to meet the IVDR (In vitro diagnostic medical devices regulation) regulatory standards.

Rhythm Biosciences is committed to working with likeminded global partners to achieve commercialisation and distribution of these simple solutions.


Our Mission

Rhythm Biosciences is committed to saving lives through early detection of cancers using simple and accurate diagnostic technology

Rhythm Biosciences Timeline

2003 - 2016

CSIRO Research and Development

Dec 2017

Rhythm Bio Lists on the ASX

Jan 2018

Development Program Commences

Feb 2019

Clinical Trial Program Commences

May 2019

ISO Certification

Jan 2018 - Nov 2020

Patents Secured in 21 Countries

Dec 2020

Global Manufacturer Appointed

Nov 2021

Clinical Trial Complete (RHY-001)

Nov 2021

CE Mark Granted for ColoSTAT®

Nov 2022

ColoSTAT® Authorised for Sale in New Zealand

May 2023

UKCA Mark Granted and Strategic Partnership with LINK Medical Solutions

Jan 2024

RHY001 Study - Submit Publication

International Market Entry

Pipeline Activities - Other Cancers

TGA Submission


Leveraging the proprietary immunoassay, developed for our ColoSTAT® blood test, Rhythm Biosciences is investigating the feasibility of using this technology to establish diagnostic tests for detection of other cancer types.

Pipeline Stages

Cancer Target
Theoretical Analysis of Biomarker Potential
Serum and Algorithm Analysis
Risk Analysis ➝ Enter Stage 2
Agilex Biolabs P/L
Baker Institute
On Hold
On Hold

About us:



Rhythm Biosciences

Bio21 Institute
30 Flemington Road
Parkville VIC 3010

Keep up to date:

Please provide your full name
You must provide an email address

Connect with us: